HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of switching from topical beta-blockers to latanoprost on intraocular pressure in patients with normal-tension glaucoma.

AbstractAIMS:
The effects of switching from topical beta-blockers (beta) to latanoprost (LA) on intraocular pressure (IOP) and IOP-reduction rate (IOP-RR) in patients with normal-tension glaucoma (NTG) were investigated.
SUBJECTS AND METHODS:
Sixty (60) NTG patients (60 eyes) were divided into three equal groups receiving carteolol hydrochloride (group A), nipradilol (group B), and betaxolol hydrochloride (group C) twice-daily for 3 months. The drugs were changed to topical LA administered once-daily for the next 3 months.
RESULTS:
Baseline IOP was 14.4 +/- 0.9, 14.6 +/- 0.6, and 14.6 +/- 0.9 mmHg in groups A, B, and C, respectively. At 3 months, IOP was 12.4 +/- 0.6, 13.4 +/- 0.6, and 12.9 +/- 0.8 mmHg and 10.5 +/- 0.5, 11.1 +/- 0.8, and 11.7 +/- 0.8 mmHg at 6 months in groups A, B, and C, respectively. At 3 months, IOP-RR was 10.4 +/- 5.5, 9.5 +/- 2.6, and 10.8 +/- 4.7% and 24.1 +/- 4.3, 22.9 +/- 5.9, and 19.4 +/- 3.8% at 6 months in groups A, B, and C, respectively. The groups did not significantly differ in the first 3 months regarding IOP and IOP-RR. Switching to LA significantly decreased IOP and increased IOP-RR in all groups.
CONCLUSION:
In NTG patients, LA reduced IOP more effectively than the beta tested.
AuthorsYoko Ikeda, Kazuhiko Mori, Takeshi Ishibashi, Shigeta Naruse, Nobuko Nakajima, Shigeru Kinoshita
JournalJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics (J Ocul Pharmacol Ther) Vol. 24 Issue 2 Pg. 230-4 (Apr 2008) ISSN: 1080-7683 [Print] United States
PMID18341431 (Publication Type: Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Ophthalmic Solutions
  • Propanolamines
  • Prostaglandins F, Synthetic
  • Latanoprost
  • Carteolol
  • nipradilol
  • Betaxolol
Topics
  • Adrenergic beta-Antagonists (pharmacology)
  • Antihypertensive Agents (pharmacology)
  • Betaxolol (pharmacology)
  • Carteolol (pharmacology)
  • Female
  • Glaucoma, Open-Angle (drug therapy, physiopathology)
  • Humans
  • Intraocular Pressure (drug effects)
  • Latanoprost
  • Male
  • Middle Aged
  • Ophthalmic Solutions
  • Propanolamines (pharmacology)
  • Prospective Studies
  • Prostaglandins F, Synthetic (pharmacology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: